{"url":"https://lda.senate.gov/api/v1/filings/b2dcb369-cd8d-4a54-bbd0-596da968b599/","filing_uuid":"b2dcb369-cd8d-4a54-bbd0-596da968b599","filing_type":"Q2Y","filing_type_display":"2nd Quarter - Report (No Activity)","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b2dcb369-cd8d-4a54-bbd0-596da968b599/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert Van Heuvelen","dt_posted":"2021-07-20T20:15:01.387000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"440 1st St, NW","registrant_address_2":"SUITE 440","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":321874,"url":"https://lda.senate.gov/api/v1/registrants/321874/","house_registrant_id":39614,"name":"VAN HEUVELEN STRATEGIES, LLC","description":"&#226;€‹Strategic consulting and lobbying","address_1":"440 1st St, NW","address_2":"SUITE 440","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT VAN HEUVELEN","contact_telephone":"","dt_updated":"2022-04-06T16:08:35.515010-04:00"},"client":{"id":186934,"url":"https://lda.senate.gov/api/v1/clients/186934/","client_id":797,"name":"AV THERAPEUTICS INC.","general_description":"Developer of cancer therapeutics and immunotherapeutic vaccines&#226;€‹.&#226;€‹","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-09-15"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}